Industries > Pharma > Global Contraceptive Devices Market Forecast to 2027

Global Contraceptive Devices Market Forecast to 2027

Male Condoms, Female Condoms, Diaphragms, Sponges, Vaginal Rings, Subdermal/Contraceptive Implants, Intra-uterine Devices (IUDs), Copper IUD, Hormonal IUD

PUBLISHED: 20 December 2017
PAGES: 186
PRODUCT CODE: PHA0271

Clear
WOOCS 2.2.1

The global contraceptive devices market is expected to grow at a CAGR of 7.5% in the first half of the forecast period. In 2016, the market was estimated at $12.1bn and dominated by the condoms submarket followed by the IUD submarket.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 186-page report you will receive 67 tables and 84 figures– all unavailable elsewhere.

The 186-page report provides clear detailed insight into the global contraceptive devices market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Global Contraceptive Devices Market Forecast to 2027

• This report also breaks down the revenue forecast for the global contraceptive devices market by type:
– Condoms:
Male and Female
– Diaphragms
– Sponges
– Vaginal Rigs
– Subdermal/Contraceptive Implants
– IUDs:
Copper IUD and Hormonal IUD

• This report provides individual revenue forecasts to 2027 for these regional and national markets:
– North America:
US & Canada
– Europe: the UK, Germany, France, Italy, Rest of Europe
– Asia-Pacific: China, Japan, India, Rest of Asia-Pacific
Rest of the World (RoW): Latin America, Middle East & Africa

Global Contraceptive Devices Market Forecast to 2027

• This report discusses the SWOT Analysis and PEST Analysis of the global contraceptive devices market.

• Our study discusses the selected leading companies that are the major players in the global contraceptive devices market:
– Bayer AG
– Reckitt Benckiser Group plc
– Merck Sharp & Dohme Corp.
– Church & Dwight Co., Inc.
– Teva Pharmaceutical Industries, Ltd.
– Allergan plc
– Ansell Limited (Now Humanwell)
– The Female Health Company (a division of VERU Inc.)
– Karex Industries
– Mayer Laboratories
– Kessel Medintim GmbH
– Okamato Industries, Inc.
– Agile Therapeutics, Inc.
– Eurogine S.L.

Visiongain’s study is intended for anyone requiring commercial analyses for the global contraceptive devices market. You find data, trends and predictions.

Buy our report today Global Contraceptive Devices Market Forecast to 2027: Male Condoms, Female Condoms, Diaphragms, Sponges, Vaginal Rings, Subdermal/Contraceptive Implants, Intra-uterine Devices (IUDs), Copper IUD, Hormonal IUD.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Contraceptive Devices Market Forecast to 2027


Download sample pages

Complete the form below to download your free sample pages for Global Contraceptive Devices Market Forecast to 2027


Latest Pharma news

Visiongain Publishes Checkpoint Inhibitors for Treating Cancer Market Report 2021-2031

We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

29 July 2021

READ

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021

READ

Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021

READ

Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021

READ

Categories